Doctors have started testing the world’s first mRNA lung cancer vaccine in patients. This vaccine, known as BNT116 and made by BioNTech, is being trialed in 34 research sites across seven countries: the UK, US, Germany, Hungary, Poland, Spain, and Turkey.















